Multinational pharma products going out-of-stock due to supply delays from overseas manufacturing facilities

Supply of multinational pharmaceutical company products continue to experience out-of-stock due to supply delays from their overseas manufacturing facilities.

Products that went out-of-stock by the supply delay are Pfizer’s ‘Nitropress Inj 2ml/1 Vial,’ Sanofi’s ‘Adenocor Inj’ and AstraZeneca’s ‘Marcaine Heavy Inj 0.5% 5*4ml.’

Sanofi-Aventis Korea ‘Adenocor Inj’ went out-of-stock due to a supp...